Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Florentine E. F. Timmer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6388-9001; OpenAlex author ID A5067858457. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 4 papers · 2022: none · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper

Papers 10

  1. Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE t… First author DOI 10.1136/jitc-2024-010222↗
  2. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE… Co-author DOI 10.1016/s2468-1253(24)00017-7↗
  3. Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial: Authors' reply. Co-author DOI 10.1016/s2468-1253(24)00162-6↗
  4. Tissue Resistance Decrease during Irreversible Electroporation of Pancreatic Cancer as a Biomarker for the Adaptive Immune Response and Survival. Co-author DOI 10.1016/j.jvir.2023.06.027↗
  5. Transcatheter CT arteriography-guided irreversible electroporation of locally advanced pancreatic adenocarcinoma: A pictorial essay. Co-author DOI 10.1111/1754-9485.13535↗
  6. Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy. Co-author DOI 10.1007/s11912-021-01057-3↗
  7. Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review. Co-author DOI 10.3390/cancers13071608↗
  8. Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Meta… First author DOI 10.3390/cancers13153902↗
  9. Pancreatic Cancer and Immunotherapy: A Clinical Overview. Co-author DOI 10.3390/cancers13164138↗
  10. Irreversible Electroporation for Locally Advanced Pancreatic Cancer. Co-author DOI 10.1016/j.tvir.2020.100675↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hester J. Scheffer · 10 shared papers, 2020–2025 · strength 1.57
  2. Martijn Ruben Meijerink · 10 shared papers, 2020–2025 · strength 1.57
  3. Bart Geboers · 10 shared papers, 2020–2025 · strength 1.57
  4. Tanja D. de Gruijl · 6 shared papers, 2021–2025 · strength 0.86
  5. Anna M E Bruynzeel · 4 shared papers, 2021–2025 · strength 0.76
  6. Alette H. Ruarus · 5 shared papers, 2020–2025 · strength 0.74
  7. Laurien G. P. H. Vroomen · 2 shared papers, 2024–2025 · strength 0.37
  8. Frank J. Lagerwaard · 2 shared papers, 2024–2025 · strength 0.37
  9. Johanna W. Wilmink · 2 shared papers, 2021 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.